Observed Signal · Sep 11, 2026 · Market Signal · Source: Five Elms Capital · Impact: 3.5/5
UrgentIQ Announces Strategic Growth Investment From Five Elms Capital
UrgentIQ, the AI-native electronic medical record (EMR) purpose-built for urgent care centers, announced today a $15M Series A...
Track Five Elms Capital Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Healthleap Raises $38M for AI-Powered Hospital Patient Screening
Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.
H1 raises $40M led by CVS Health Ventures
H1, a nine-year-old healthcare data platform, raised $40 million in a round led by CVS Health Ventures. CEO and co-founder Ariel Katz said H1 — which licenses detailed physician data to pharma companies, hospital systems and insurers — turned cash-flow and EBITDA profitable last year and is forecasting over 40% growth this year. Katz argued that being a data-first provider makes H1 less vulnerable to AI replacement and could make it a supplier to model makers. H1 was last valued at $750 million after a $100 million round in November 2021 led by Altimeter Capital, and the company has grown through acquisitions of smaller competitors and complementary businesses.
XRlabs Raises €7.48M for AI Surgical Intelligence
London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).
Receive all future signals for Five Elms Capital & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.